DTaP vaccine paediatric - Baxter International
Alternative Names: Certiva; Certiva-EULatest Information Update: 16 Mar 2011
Price :
$50 *
At a glance
- Originator North American Vaccine
- Developer Baxter International
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Market Withdrawal Diphtheria; Pertussis; Tetanus
Most Recent Events
- 27 Jun 2000 North American Vaccine has been acquired by and merged into Baxter International
- 30 Oct 1999 Withdrawn for Diphtheria in USA (IM)
- 30 Oct 1999 Withdrawn for Pertussis in USA (IM)